Skip to content
Disclosery

Saturn V Capital Management LP

Follow

13F filer, CIK 1964437, AUSTIN, TX

Saturn V Capital Management LP reported $697,467,372 across 23 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 75.59% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001964437-26-000012

Period
2026-06-30
Reported value
$697M
Holdings
23
Top 10 weight
75.59%
New
3
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
TRVInew+1,052,043$19.6M
SGMTnew+1,479,918$11.4M
IMMXadded+964,844$9.95M
CELCadded+88,414$9.25M
ZURAadded+1,361,159$8.03M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
COGTexited-626,635-$24.1M
OVIDreduced-3,503,606-$9.42M
ALMSreduced-286,632-$8.07M
ABVXreduced-23,831-$3.18M
MNPRreduced-33,650-$3.12M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001964437-26-000012, largest first. % of portfolio is the value over $697,467,372, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 889,073 shares; 2025Q1: 2,426,436 shares; 2025Q2: 3,260,570 shares; 2025Q3: 4,604,878 shares; 2025Q4: 4,496,487 shares; 2026Q1: 4,349,885 shares; 2026Q2: 4,624,101 shares 4,624,101$83M11.91%+274,216Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,135,953 shares; 2026Q1: 3,202,075 shares; 2026Q2: 2,915,443 shares 2,915,443$82M11.76%-286,632Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 648,019 shares; 2024Q4: 653,071 shares; 2025Q1: 552,926 shares; 2025Q2: 622,479 shares; 2025Q3: 801,224 shares; 2025Q4: 649,179 shares; 2026Q1: 542,696 shares; 2026Q2: 518,865 shares 518,865$69.1M9.91%-23,831Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 204,987 shares; 2024Q4: 204,285 shares; 2025Q1: 232,295 shares; 2025Q2: 544,221 shares; 2025Q3: 788,441 shares; 2025Q4: 798,940 shares; 2026Q1: 824,532 shares; 2026Q2: 852,914 shares 852,914$49.6M7.11%+28,382Timeline
IMMXIMMIX BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,999,169 shares; 2026Q1: 3,693,585 shares; 2026Q2: 4,658,429 shares 4,658,429$48M6.89%+964,844Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 886,332 shares; 2025Q4: 1,140,033 shares; 2026Q1: 1,201,402 shares; 2026Q2: 1,314,122 shares 1,314,122$45.4M6.52%+112,720Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 206,952 shares; 2025Q3: 300,610 shares; 2025Q4: 248,070 shares; 2026Q1: 162,961 shares; 2026Q2: 160,938 shares 160,938$38.8M5.56%-2,023Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 946,335 shares; 2024Q4: 1,063,783 shares; 2025Q1: 1,093,677 shares; 2025Q2: 1,185,520 shares; 2025Q3: 473,828 shares; 2025Q4: 317,095 shares; 2026Q1: 281,904 shares; 2026Q2: 370,318 shares 370,318$38.7M5.55%+88,414Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 511,041 shares; 2024Q4: 509,406 shares; 2025Q1: 518,177 shares; 2025Q2: 396,115 shares; 2025Q3: 340,897 shares; 2025Q4: 298,429 shares; 2026Q1: 449,926 shares; 2026Q2: 524,730 shares 524,730$38.4M5.5%+74,804Timeline
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,896,588 shares; 2026Q2: 3,303,686 shares 3,303,686$34M4.88%+407,098Timeline
XFORX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,800,530 shares; 2026Q1: 6,456,646 shares; 2026Q2: 6,973,343 shares 6,973,343$32.6M4.67%+516,697Timeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 155,370 shares; 2025Q4: 325,701 shares; 2026Q1: 345,626 shares; 2026Q2: 311,976 shares 311,976$28.9M4.14%-33,650Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,455,429 shares; 2025Q3: 2,674,469 shares; 2025Q4: 1,788,616 shares; 2026Q1: 966,609 shares; 2026Q2: 1,057,493 shares 1,057,493$23.5M3.37%+90,884Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,052,043 shares 1,052,043$19.6M2.81%newTimeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 739,960 shares; 2026Q2: 2,101,119 shares 2,101,119$12.4M1.78%+1,361,159Timeline
SGMTSAGIMET BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,479,918 shares 1,479,918$11.4M1.64%newTimeline
OCSOCULIS HOLDING AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 516,761 shares; 2026Q1: 516,761 shares; 2026Q2: 684,880 shares 684,880$9.5M1.36%+168,119Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,856,799 shares; 2026Q1: 3,863,445 shares; 2026Q2: 3,869,056 shares 3,869,056$7.85M1.13%+5,611Timeline
VIRVIR BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 770,643 shares 770,643$7.85M1.13%newTimeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 7,735,386 shares; 2026Q1: 10,949,084 shares; 2026Q2: 8,392,288 shares 8,392,288$7.32M1.05%-2,556,796Timeline
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 88,999 shares; 2026Q2: 182,829 shares 182,829$4.82M0.69%+93,830Timeline
MSLESATELLOS BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 350,000 shares; 2026Q2: 350,000 shares 350,000$2.72M0.39%0Timeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,500,000 shares; 2026Q1: 4,166,666 shares; 2026Q2: 663,060 shares 663,060$1.78M0.26%-3,503,606Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
COGTCOGENT BIOSCIENCES INC626,635$24.1Mshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001964437-26-000012 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001964437-26-000012 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001964437-26-000005 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001964437-26-000003 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001964437-25-000013 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001964437-25-000008 Quarter ended 2025-06-302025-08-13acceptance time not in the bulk data set
13F-HR 0001964437-25-000005 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001964437-25-000003 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001964437-24-000011 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001964437-24-000007 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001964437-24-000004 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001964437-24-000002 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001964437-23-000007 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001964437-23-000004 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001104659-23-060321 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001104659-23-014959 Quarter ended 2022-12-312023-02-09acceptance time not in the bulk data set